Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study

<div>Correlation between periprocedural glycemic variability (expressed as CONGA-2, CONGA-1, and MAGE-down) and postprocedural troponin I increase. CONGA-1: continuous overall net glycemic action at 1 hour; CONGA-2: continuous overall net glycemic action at 2 hours; MAGE-down: mean amplitude glycemic peak-to-nadir excursions.</div>

Journal of Diabetes Research

fig4

Figure 4

Figure 4: Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 

Figure 4 | Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 